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ttp://dx.doi.org/10.1016/j.ajpath.2013.05.002Liver disease affects millions of patients each year. The ﬁeld of regenerative medicine promises
alternative therapeutic approaches, including the potential to bioengineer replacement hepatic tissue.
One approach combines cells with acellular scaffolds derived from animal tissue. The goal of this study
was to scale up our rodent liver decellularization method to livers of a clinically relevant size. Porcine
livers were cannulated via the hepatic artery, then perfused with PBS, followed by successive Triton X-
100 and SDS solutions in saline buffer. After several days of rinsing, decellularized liver samples were
histologically analyzed. In addition, biopsy specimens of decellularized scaffolds were seeded with
hepatoblastoma cells for cytotoxicity testing or implanted s.c. into rodents to investigate scaffold
immunogenicity. Histological staining conﬁrmed cellular clearance from pig livers, with removal of
nuclei and cytoskeletal components and widespread preservation of structural extracellular molecules.
Scanning electron microscopy conﬁrmed preservation of an intact liver capsule, a porous acellular
lattice structure with intact vessels and striated basement membrane. Liver scaffolds supported cells
over 21 days, and no increased immune response was seen with either allogeneic (rat-into-rat) or
xenogeneic (pig-into-rat) transplants over 28 days, compared with shameoperated on controls. These
studies demonstrate that successful decellularization of the porcine liver could be achieved with
protocols developed for rat livers, yielding nonimmunogenic scaffolds for future hepatic bioengineering
studies. (Am J Pathol 2013, 183: 558e565; http://dx.doi.org/10.1016/j.ajpath.2013.05.002)Supported by NIH grants R01 DK058614 and R01 DK065096 (B.E.P.).
S.-H.M.-S. and D.C.S. contributed equally to this work.Within the United States alone, tens of thousands of patients
are awaiting a liver transplant, with only a few thousand
donor organs available annually.1 This widening mismatch
has led physicians and researchers to pursue alternative
therapies for chronic liver disease, including in situ cell-
based therapies or xenotransplantation of organs.2e4 The
ﬁeld of regenerative medicine offers another approach, in
which elements of both would be combined for the bioen-
gineering of neo-organs for transplantation.5,6
The concept of whole liver tissue engineering aims to
combine patient-speciﬁc autologous hepatocytes or hepatic
progenitor cells and a carrying platform, or scaffold, to
allow for three-dimensional tissue growth and permit the
complex cellularity of hepatic tissue. Use of decellularized
organ matrices preserves the natural extracellular matrix
(ECM) proteins and growth factors that guide cell attach-
ment and proliferation in an organ-speciﬁc manner.7 Properstigative Pathology.
.processing of the matrix scaffolds removes all cytotoxic
chemicals from the decellularization process and performs
complete degradation of donor nucleic acids to prevent an
adverse host immune response.8 These bioengineered livers
have the ultimate potential to surpass the current allograft
gold standard.
The process begins by removing the native cellular com-
ponents from a donor tissue using detergents and enzymes and
leaving behind an ECM scaffold with preserved vasculature
and essential biological factors. The concept has been applied
to many tissues, including the heart,9,10 lungs,11e14 bladder,15
blood vessels,16,17 muscle,18 intestines,19,20 trachea,21e23
kidney,7,24,25 and liver.26e30 Each detergent, enzyme, washing
buffer, and sterilization technique used to decellularize a tissue
Decellularized Porcine Livercan have a direct inﬂuence on the host remodeling response and
functional outcome.31 In a previous study, decellularizedmatrix
scaffolds were immunologically favorable up until cells were
added to the scaffolding material, where proinﬂammatory
macrophages were activated.32 To evaluate whether a decellu-
larized tissue represents a viable scaffold option, the generated
matrices need to be implanted and evaluated over time, without
cells, to allow a host’s immune cells to inﬁltrate and respond to
the material.33 The initial response can begin as early as 2 days
and last for months.34 During that time, the environment from
both the host itself and the degrading matrix material can
inﬂuence the phenotype of the host immune cells switching
between activation states that will determine the future clinical
viability of the biological matrix material.35e37 Triggering of
proinﬂammatory macrophage activation results in the release of
cytokines, growth factors, proteolytic enzymes, and reactive
oxygen and nitrogen intermediates that will greatly inhibit the
integration of the biomaterial with the host tissue.38 Studies on
the immunogenicity of decellularized whole tissue are limited,
and a key criterion of transplantation viability will be evaluating
the activation of host macrophages toward the classically
proinﬂammatory phenotype (M1) or the regenerative and repair
phenotype (M2).
The objectives of the current study were to generate
a decellularized porcine liver by scaling up our previously
established rodent perfusion protocol,28 characterize the
resultant scaffold, and compare the in vivo immunological
response of a rodent host between allograft and xenograft
decellularized liver matrices. We hypothesized that both
tissues would elicit a similar host response as the result of
the high levels of preservation the ECM protein structures
share between species.39 The generation of large-scale
hepatic tissue platforms, and an understanding of the
inherent immune response by a host species, will be vital in
producing implantable bioengineered livers.
Materials and Methods
Apparatus and Reagents
Triton X-100, scanning electron microscopy (SEM)egrade
glutaraldehyde (G5882), SDS (L5750), and all other
reagents were purchased from Sigma-Aldrich (St. Louis,
MO), unless otherwise stated. The PBS salts were obtained
from Thermo Fisher Scientiﬁc Inc. (Pittsburgh, PA), and
sodium heparin was obtained from SAGENT Pharmaceuti-
cals (Schaumburg, IL). Masterﬂex L/S Digital Drive peri-
staltic pumps, Easy-Load II pump heads, and silicone tubing
were purchased from Cole-Palmer Instrument Co (Vernon
Hills, IL). Liberate Antibody Binding solution (24310) was
purchased from Polysciences Inc. (Warrington, PA). Serum-
free protein block (X0909), antibody diluent (S3022), dual
endogenous enzyme block (S2003), and primary antibodies
were purchased from Dako NA Inc. (Carpentaria, CA).
Vectastain RTU ABC Reagent (PK-7100), ImmPACT DAB
[diaminobenzidine] Peroxidase Substrate Kit (SK-4105),The American Journal of Pathology - ajp.amjpathol.orgavidin/biotin blocking kit (SP-2001), and other secondary
antibodies were obtained from Vector Laboratories (Burlin-
game, CA). Other primary antibodies were purchased from
Abcam plc (Cambridge, MA), Santa Cruz Biotechnology
Inc. (Santa Cruz, CA), and AbD Serotec (Raleigh, NC). An
ApopTag Peroxidase In Situ Apoptosis Detection Kit
(S7100) was purchased fromMillipore (Billerica, MA). Fetal
bovine serum, Dulbecco’s minimum essential medium F-12,
and penicillin-streptomycin solution were from HyClone
Laboratories (Logan, UT). Surgipath MM24 Mounting
Medium (3801122) was obtained from Leica Microsystems
GmbH (Wetzlar, Germany). Fischer rats F344 were obtained
from Harlan Laboratories Inc. (Indianapolis, IN).
Liver Decellularization
Young adult pigs (20 to 25 kg) were i.v. heparinized with 400
U/kg, and then euthanized according to Institutional Animal
Care and Use Committee guidelines. Livers (450 to 500 g)
were harvested and placed on ice, and then cannulated via the
hepatic artery. Organs were perfused with ice-cold PBS con-
taining 10 U/mL sodium heparin until circulated perfusate ran
clear. Livers were perfused at 50 mL/minute with increasing
concentrations of Triton X-100 (1%, 2%, and then 3%) in
chilled PBS, then 0.1% room temperature SDS in PBS. Livers
were rinsed via the hepatic artery with chilled PBS for several
days at the same ﬂow rate, then cut into pieces (2 cm thick) and
placed in PBS-containing antibiotic-antimycotic supplements
on a shaker at 4C for a further 2 to 3 days. Rat liver decel-
lularization was performed as previously described.28 To
generate liver scaffolds, decellularized liver pieces were sliced
into transverse sections (1 mm thick) and placed ﬂat. Then,
a biopsy was performed with a 15-mm-diameter punch.
Scaffoldswere placed in PBS, sterilized via 1Mrad (10kGy)g
irradiation, and then stored at 4C until use.
Histological Analysis
Samples for histological staining were ﬁxed overnight in 10%
neutral-buffered formalin, then transferred to 60% ethanol
before dehydration in successive alcohols, immersion in
xylene, and ﬁnal embedding in parafﬁn wax. Samples were
divided into sections onto glass slides and stored at 4C.
Rehydrated sections were stained with histochemical dyes for
either H&E (black/pink for nuclei/tissue, respectively) or
Masson’s trichrome method (blue/black/red for collagen/
nuclei/cytoplasm, respectively), according to established
protocols.40,41 All images were captured on a Leica Micro-
systems (Wetzlar, Germany) DM4000B upright microscope
with ImagePro (MediaCybernetics, Rockville, MD) software
version 6.3. For SEM, samples were ﬁxed in 2.5% SEM-grade
glutaraldehyde in PBS, then dehydrated in successive alcohols
before critical point drying with carbon dioxide. Samples were
sputter coated and visualized via a Hitachi S-2600N SEMwith
accompanying manufacturer image-capture software (Hitachi
High Technologies America, Inc., Gaithersburg, MD).559
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Antigen retrieval (when necessary) was performed on rehy-
drated sections with Liberate Antibody Binding solution,
followed by quenching of endogenous peroxidase activity
with dual endogenous enzyme block, then serum-free
protein-, avidin-, and biotin-blocking steps. Primary anti-
bodies or isotype controls were diluted in antibody diluent at
the same protein concentration and incubated on sections
overnight at 4C. Negative controls lacked primary antibody.
Sections were blocked again before application of secondary
antibodies also diluted in antibody diluent, and incubated for
1 hour at room temperature. Slides were washed with Tris-
buffered saline, incubated with ABC Reagent (Dako) for 30
minutes at room temperature, and then washed again with
Tris-buffered saline. Once diaminobenzidine (DAB) chro-
mogen was developed, sections were counterstained with
hematoxylin, dehydrated, and mounted in nonaqueous
mounting medium. Antibodies used are listed in Table 1, and
controls are given in Supplemental Figure S1. TUNEL
staining followed manufacturer’s protocols, with ABC
Reagent incubation, DAB chromogen development, and
hematoxylin counterstaining, as previously described.
Liver Scaffold Seeding
Sterilized scaffolds in PBS were equilibrated in fetal bovine
serum overnight at 4C, then soaked in hepatocyte medium
(Dulbecco’s minimum essential medium F-12 with 10%
fetal bovine serum and 1% penicillin-streptomycin) brieﬂy
before static seeding with hepatoblastoma (HepG2) cells.
Seeded scaffolds were maintained in hepatocyte medium in
a humidiﬁed environment at 37C with 5% CO2 up to 21
days. At harvest, scaffolds were washed in PBS and ﬁxed
for histological analysis.
In Vivo Implantation of Scaffolds
Male Fischer F344 rats (180 g)were handled and anesthetized
according to Institutional Animal Care and Use Committee
guidelines. Irradiated decellularized pig or rat liver scaffoldsTable 1 Antibodies Used for Immunochemical Staining
Primary antibody Isotype control Secondary antibody
Anti-CD3 Mouse IgG Biotinylated anti-mouse IgG
Dako A0452 Vector I-2000 Vector BA-2001
Anti-CD68 Mouse IgG Biotinylated anti-mouse IgG
Abcam ab31630 Vector I-2000 Vector BA-2001
Anti-CD86 Rabbit IgG Biotinylated anti-rabbit IgG
Abcam ab53004 Vector I-1000 Vector BA-1000
Anti-CD206 Rabbit IgG Biotinylated anti-rabbit IgG
Abcam ab64693 Vector I-1000 Vector BA-1000
Anti-elastin Mouse IgG Biotinylated anti-mouse IgG
Abcam ab9519 Vector I-2000 Vector BA-2001
Anti-laminin Rabbit IgG Biotinylated anti-rabbit IgG
Sigma-Aldrich
L9393
Vector I-1000 Vector BA-1000
560were implanted s.c. into the fat pad between the shoulder
blades. Scaffoldswere explanted after 2, 7, 14, and28days and
ﬁxed for histological analysis. Blood was collected at corre-
sponding time points or after euthanasia for complete blood
cell count analysis via a Siemens ADVIA 120 Hematology
system (Siemens Medical Solutions USA Inc., Malvern, PA).
Statistical Analysis
Statistical analysis was performed using two-way analysis
of variance, with Tukey’s post hoc tests for comparisons
between individual groups and time. P < 0.05 was consid-
ered signiﬁcant. All studies were performed in triplicate or
higher. Values are expressed as means SD, with statistical
analyses performed on GraphPad (La Jolla, CA) Prism
software version 6.0a.
Results
Decellularization of the Porcine Liver
Multiple decellularization techniques exist, including diffu-
sion for thin or laminar tissue and perfusion for larger,
complex, solid organs. Herein, we used perfusion techniques
applied to the rat liver with sequential stages of Triton X-100
at 1%, 2%, and 3%, followed by 0.1% SDS (Figure 1), which
resulted in a marked tonal difference in the organ (Figure 1,
AeC). Macroscopic and microscopic vessel branching was
visible below the tissue surface (Figure 1, D and E, respec-
tively). A histological examination demonstrated the loss of
cellularity from normal to decellularized tissue, with a lack of
nuclear hematoxylin staining (Figure 1, F and H) and clear-
ance of cellular cytoplasmic keratins, leaving behind
a collagenous-rich, acellular matrix, as denoted by Masson’s
trichrome staining matrix (Figure 1, G and I).
Preservation of Liver Structures
A key rationale for the use of decellularized scaffolds is the
preservation of natural components of the organ and ECM
(Figure 2). Immunohistochemical staining showed the positive
presence of elastin and laminin surrounding preserved vessel
structures (Figure 2, A and B), and highly distinct tissue
topographies were also preserved after decellularization, as
demonstrated by the comparison of the capsule, parenchymal
tissue, and vessel structures (Figure 2C). The preserved capsule
showed a tight matrix with limited porosity (Figure 1D),
enough to prevent leakage of perfused reagents (data not
shown). Preserved vessel structures demonstrated a smooth
and intact wall (Figure 2E). Finally, the parenchymal space of
the decellularized tissue showed an open and highly porous
structure, applicable for recellularization studies (Figure 2F).
Cytotoxicity of Decellularized Liver Matrix
The preparation of decellularized matrices involves cell and
organelle lysis and digestion, through the application ofajp.amjpathol.org - The American Journal of Pathology
Figure 1 Porcine liver decellularization. Whole native liver (A) before
perfusion with Triton X-100 (B) and SDS (C). Indicated by panels on the
SDS-treated liver, the preserved major (D) and minor (E) vessels are visible
at the end of the protocol. Native liver sections stained with H&E (F) and
Masson’s trichrome (G) help illustrate the complete cellular removal seen in
their respective decellularized counterparts (H and I). Arrows indicate
preserved vessels in decellularized matrices compared with native struc-
tures. Scale bar Z 100 mm (FeI).
Figure 3 In vitro noncytotoxicity of porcine liver matrix scaffolds.
HepG2 cells were statically seeded onto scaffolds and cultured out to 21
days to determine whether any cytotoxic compounds would be released
from the decellularized matrices. TUNEL staining of the scaffolds at 7 (A)
and 21 (B) days indicated minimal apoptotic response of HepG2 cells to
liver scaffolds, in both close contact with scaffolds and within cell masses
(arrows), compared with DNase-treated positive control samples (C). LM,
liver matrix. Scale bar Z 50 mm (AeC).
Decellularized Porcine Liverdetergents and, in some cases, enzymatic means, but the resul-
tantmatricesmust demonstrate noncytotoxocity and, moreover,
scaffolds must support cell growth to be considered for organ
bioengineering purposes (Figure 3). HepG2 cells were statically
seeded onto decellularized liver scaffolds and maintained forFigure 2 Preservation of discreet ultrastructural components. Positive
immunostaining for vascular elements elastin (ELN; A) and laminin (LN; B).
C: Scanning electron micrographs of the decellularized porcine liver showed
distinct areas of the capsule, vessels, and parenchyma, shown under higher
magniﬁcation in DeF, respectively. Original magniﬁcation: 50 (C); 200
(DeF). Scale bar Z 200 mm (A and B).
The American Journal of Pathology - ajp.amjpathol.orgup to 21 days, when dense cell layers were observed. Cells at
day 7 (Figure 3A) and day 21 (Figure 3B) did not exhibit
apoptotic markers, as displayed in control samples with
degradedDNA (Figure 3C) and conﬁrmed by TUNEL staining.
Cells were observed attached to the surfaces of matrices, with
minimal penetration into the liver matrix scaffold.
Immunogenicity of Liver Matrix Scaffolds
To investigate the immunogenicity of our decellularized
scaffolds (rodent and porcine), we implanted naked scaffolds
(Figure 4, C and D) into the s.c. dorsal adipose tissue of rats
(Figure 4A). Scaffolds were recovered (Figure 4B) with
surrounding tissue intact to measure cellular inﬁltration and
host response, with no visible ﬁbrous encapsulation of scaf-
folds or exudates observed at implantation sites. After 7 days
(Figure 4, E and F), cells had migrated into both allogeneic
(rat) and xenogeneic (porcine) scaffolding, with no signs of an
inﬂammatory response.Over 28 days (Figure 4,G andH), host
cells continued to populate each recovered scaffold, with no
noticeable adverse host response surrounding the matrices.
Systemic white blood cell counts were collected from animals
during the experiment and compared with rodents who
underwent implantation surgeries, but received no matrix
implant (sham). Total white blood cell counts (Figure 4I),
lymphocyte counts (Figure 4J), and monocyte counts
(Figure 4K) were not signiﬁcantly different between groups
(P > 0.05) at 2, 7, 14, and 28 days, indicating no major
systemic host response compared with normal surgical
recovery. Lymphocyte count results were supported by little to
noCD3þT-cell activation at the implantation site, as seen over
the 28 days in either group (Figure 5, A andB).Many cells that
inﬁltrated the implanted scaffolds were positive for the pan-
macrophage phenotypic marker, CD68 (Figure 5, C and D).
However, as seen previously, neither the monocyte counts (as
macrophage precursors) (Figure 4K) nor the cells expressing
markers indicating adoption of the M1 (CD86þ) or M2
(CD206þ) phenotypes (Figure 5, EeH) showed an increase.
Discussion
In this study, we developed a successful protocol for the
generation of clinically relevant sized decellularized porcine561
Figure 4 Host response. In all groups, grafts
were implanted s.c. in the dorsal adipose tissue
of a given animal (A) and harvested intact for
histological analysis (B), with no visible encap-
sulation or exudate at the implantation site.
Arrows denote the four scaffolds implanted per
animal. C and D: H&E staining of nonimplanted
biopsy specimens of decellularized allogeneic
(Allo; rat) and xenogeneic (Xeno; pig) livers
indicated no cellular material in the scaffolds
before implantation. E and F: Day 7 (d7) allo-
geneic and xenogeneic explants indicated
cellular inﬁltration of the scaffolding material,
with no ﬁbrous encapsulation under microscopic
examination. G and H: Day 28 (d28) explants
continued to indicate cellular activity inside
both allogeneic and xenogeneic scaffolding
materials, with no encapsulation of the scaffold.
Systemic white blood cell analysis over the
length of the experiment indicated no signiﬁ-
cant difference (P > 0.05) between implanted
allograft or xenograft scaffolds compared with
shameoperated on animals (no scaffold
implantation) in total white blood cell count (I),
lymphocyte count (J), or monocyte count (K),
indicating no major host response to the ECM
materials. Signiﬁcantly decreased counts in all
groups were observed over time (P < 0.05).
Scale bar Z 100 mm (CeH).
Mirmalek-Sani et allivers, as derived from our previous rodent liver decellulari-
zation method.28 These studies demonstrated, after detergent
perfusion and rinsing, cellular clearance and preservation of
the vasculature tree and ECM proteins, as shown by our
previous scaffolds24,28 or scaffolds generated by other
groups.26,30,42 Maintenance of patent blood vessel structures
provides an essential nutrient distribution network for whole
organ regenerative studies. Without blood vessel structures,
static transport limitations within the scaffolding material
will generate necrotic pockets because cell proliferation
would leave the cells most distant from nutrient sources
starved.38 With blood vessel structures, we avoid such a562detrimental situation and instead replicate the body’s nutrient
delivery and toxin removal by perfusing the vasculature at
model pressure and ﬂow conditions.
The vasculature also provides a lattice structure for endo-
thelial cell attachment and proliferation that will be crucial for
prevention of thrombosis on vascular anastomosis within the
recipient. Speciﬁcally for the liver, an implantable unit will
need to be directly connected to the host vasculature. A
previous study demonstrated the successful decellularization
and implantation25 of porcine kidney scaffolds, which con-
ﬁrmed that an acellular matrix could withstand the strain of
surgical implantation and exposure to arterial blood ﬂow. Ourajp.amjpathol.org - The American Journal of Pathology
Figure 5 Cell-speciﬁc activation. Anti-CD3þ
staining of allogeneic (Allo; A) and xenogeneic
(Xeno; B) liver explant tissues on early [day 7
(d7)] and late [day 28 (d28)] time points indi-
cated minimal or no CD3þ T-cell activation. CD68þ
pan-macrophages were seen within implanted
allogeneic (C) and xenogeneic (D) matrices over
the duration of the experiment. Staining for
macrophage polarity indicated minimal or no
activation of CD86þ (M1) in either allogeneic (E)
or xenogeneic (F) scaffolds over early and late
time points. G and H: Similar results were observed
for the presence of CD206þ (M2) macrophages,
with limited positive staining in xenogeneic
samples. Scale bar Z 50 mm (AeH).
Decellularized Porcine Liverliver scaffolds have also maintained the integrity of the
organ’s capsule, critical for preventing increases in perme-
ability and circulation leaks that would be detrimental in
maintaining the closed-loop vasculature.
The preservation of basement membrane proteins, such as
collagens, ﬁbronectin (data not shown), elastins, and lam-
inins, has been shown to maintain hepatic cell function for
longer time periods than classic substrates.43e45 As well as
primary cells, embryonic and mesenchymal stem cells have
been infused into decellularized scaffolds and shown to
develop organ-speciﬁc phenotypes and functions simply
through scaffold interaction.7,42 Our present studies focused
on minimizing the cytotoxicity of our scaffold material and
demonstrated no contact or soluble toxicity, with mainte-
nance of HepG2 hepatoblastoma cells over 21 days. Our
follow-up research is focused on the co-culture of primary
hepatic and endothelial cells on the matrix material for the
development of a functional and implantable liver device.
Related to cellular engraftment, viability, and prolifera-
tion, there are ongoing investigations into the effects of g
sterilization and peracetic acid chemical sterilization on
scaffold elasticity.46 It has been reported that the elastic
modulus of the underlying substrate can directly affect cell
attachment, behavior, and viability.47,48 Anecdotal observa-
tions suggested signiﬁcant alteration of the physical scaffold
stiffness pre-g and post-g sterilization, supporting previous
studies.49,50 However, speciﬁcs into the impact these changes
have on tissue regeneration are limited.8We believe each step
in our decellularization protocol should focus only on the
removal of the donor cellular material, while minimizing the
impact on inherent mechanical properties of the substratum.
Ongoing studies are examining alternatives to irradiation to
achieve whole organ sterilization before reseeding.The American Journal of Pathology - ajp.amjpathol.orgBefore progressing to the transplantation of regenerated liver
tissue, a basic understanding of the host immune response
toward the scaffolding material is essential to determine
whether a decellularized biomaterial is able to affect proin-
ﬂammatory macrophage activation.38,51 Our studies assessed
the response to rodent and porcine decellularized liver biopsy
specimens within a rodent model (allograft versus xenograft
proteins). In doing so, we reafﬁrmed the similarity of the
scaffold components between species and reduced future
concerns over matrix properties when evaluating host immune
response to a recellularized scaffold. The inﬂuxofmacrophages
without activation, as seen with our scaffold materials, is not
uncommon and may, instead, be an indication of the inﬂuence
of potential factors stored in the matrix material itself.32,35
In summary, our protocol adaptation was able to generate
large-scale organ scaffolds of a clinically relevant size for
further investigations of organ regeneration. Our matrices
preserved essential ECM proteins for cell engraftment and
function, as well as the vasculature required for nutrient
distribution for whole organ reseeding. Neither our previ-
ously developed rodent scaffolds nor newly prepared porcine
scaffolds elicited a host immune response, while also readily
being colonized by host cells. These results indicate that
a naturally derived ECM scaffold is viable for the next stages
of regeneration of a bioengineered hepatic tissue.Acknowledgments
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